Estimation of Secondary Skin Cancer Risk Due To Electron Contamination in 18-MV LINAC-Based Prostate Radiotherapy

Estimation of Secondary Skin Cancer Risk Due To Electron Contamination in 18-MV LINAC-Based Prostate Radiotherapy

Introduction Accurate estimation of the skin-absorbed dose in external radiation therapy is essential to estimating the probability of secondary carcinogenesis induction Materials and Methods Electron contamination in prostate radiotherapy was investigated using the Monte Carlo (MC) code calculation...

Full description

Bibliographic Details
Main Authors:	Seyed Mostafa Ghavami, Hosein Ghiasi
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2016-12-01
Series:	Iranian Journal of Medical Physics
Subjects:	Skin Cancer Monte Carlo Method High Energy Radiotherapy Absolute Risk Reduction Prostate cancer Radiotherapy
Online Access:	http://ijmp.mums.ac.ir/article_8292_56c263ad8ebf8cf7f5bd0f4a8f29a449.pdf

Similar Items

Enhancement of the Dose on 12 MV Linac with Free Flattening Filter Mode
by: Zeghari A., et al.
Published: (2019-08-01)

Characterization of the Radiation Contamination in an 18MV Linac Treatment Room Made of some Nanoparticles Mixture
by: Sara Ghanavati, et al.
Published: (2023-09-01)

Monte Carlo simulations in radiotherapy dosimetry
by: Pedro Andreo
Published: (2018-06-01)

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
by: Daniel Wegener, et al.
Published: (2022-09-01)

Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
by: Nadia Gisella Di Muzio, et al.
Published: (2021-10-01)

ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer
by: Alan Dal Pra, et al.
Published: (2023-07-01)

Current Approaches in Prostate Cancer Radiotherapy
by: Didem Karacetin
Published: (2021-01-01)

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
by: Lin-Rui Gao, et al.
Published: (2023-01-01)

Investigation and Comparison of Metal Nanoparticles on Dose Enhancement Effect in Radiotherapy Using Monte Carlo Simulation Method
by: Mohammad Reza Madi, et al.
Published: (2022-04-01)

Simulation of the 6 MV Elekta Synergy Platform linac photon beam using Geant4 Application for Tomographic Emission
by: Samir Didi, et al.
Published: (2015-01-01)

Mapping of Recurrence Sites Following Adjuvant or Salvage Radiotherapy for Prostate Cancer Patients
by: Ana Gonzalez-Moya, et al.
Published: (2022-01-01)

Quality control of radiotherapy treatment plans with electrons
by: Luciana Tourinho Campos, et al.
Published: (2019-01-01)

The Effect of Neutron Contamination on Probability of Secondary Cancer in Radiotherapy of Pelvic Region with 18-MV Photons
by: Amir Hossein Karimi, et al.
Published: (2019-06-01)

Monte Carlo verification of radiotherapy treatments with CloudMC
by: Hector Miras, et al.
Published: (2018-06-01)

SURVIVAL OF PROSTATE CANCER PATIENTS WITH COMBINATION HORMONAL-RADIOTHERAPY BETTER THAN HORMONAL THERAPY
by: Exsa Hadibrata, et al.
Published: (2020-07-01)

Investigation of Leakage and Transmission Radiation through the MLC Version I2 Applied To the Elekta Synergy 6 MV Photon Beam Linac
by: Deae-eddine KRIM, et al.
Published: (2022-11-01)

Safety and tolerability of biodegradable balloon spacers in patients undergoing radiotherapy for organ-confined prostate cancer
by: Luca Topazio, et al.
Published: (2023-06-01)

Monte Carlo Study of Fetal Dosimetry Parameters for 6 MV Photon Beam
by: Maryam Atarod, et al.
Published: (2013-01-01)

Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
by: Young Suk Kwon, et al.
Published: (2021-06-01)

A Comparison of Conventional Empirical Formula and MCNPX Code in the Estimations of Photon and Neutron Skyshine Rates for an 18MV Radiotherapy Bunker
by: Reza Eghdam-Zamiri, et al.
Published: (2021-11-01)

Dosimetric assessment and secondary cancer risk in breast radiotherapy: a Monte Carlo approach
by: Mirko Salomón Alva-Sánchez, et al.
Published: (2022-09-01)

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
by: Yeon Joo Kim, et al.
Published: (2018-04-01)

MR-Guided Radiotherapy for Prostate Cancer
by: Boris R. Tocco, et al.
Published: (2020-12-01)

Inguinal hernia in a patient with prostate cancer to be treated with photon radiotherapy
by: Takahiro Oike, et al.
Published: (2020-12-01)

Estimation of Dosimetric Parameters based on KNR and KNCSF Correction Factors for Small Field Radiation Therapy at 6 and 18 MV Linac Energies using Monte Carlo Simulation Methods
by: Rahimi S. A., et al.
Published: (2019-02-01)

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
by: Francesco Cuccia, et al.
Published: (2021-04-01)

Cone-beam computed tomography-guided online adaptive radiotherapy is feasible for prostate cancer patients
by: Lisanne G.M. Zwart, et al.
Published: (2022-04-01)

Assessment of Surface and Build-up Doses for a 6 MV Photon Beam using Parallel Plate Chamber, EBT3 Gafchromic Films, and PRIMO Monte Carlo Simulation Code
by: Mamta Mahur, et al.
Published: (2022-10-01)

Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)
by: Inés Rivero Belenchón, et al.
Published: (2023-08-01)

External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004
by: R Miralbell, et al.
Published: (2009-09-01)

Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
by: Giuseppe Sanguineti, et al.
Published: (2019-01-01)

A Population-Based Study of Secondary Prostate Cancer Risk after Radiotherapy in Male Patients with Rectal Cancer: A Retrospective Cohort Study
by: Jen-Pin Chuang, et al.
Published: (2019-04-01)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
by: Hideya Yamazaki, et al.
Published: (2021-12-01)

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy
by: Daryl Lim Joon, et al.
Published: (2023-02-01)

Evaluation of Lung Dose in Esophageal Cancer Radiotherapy Using Monte Carlo Simulation
by: Tayyeb Pourfallah, et al.
Published: (2020-02-01)

MRI-Guided Radiotherapy for Prostate Cancer: a New Paradigm
by: Jure Murgić, et al.
Published: (2022-01-01)

A New Approach to Imaging and Rapid Microbiome Identification for Prostate Cancer Patients Undergoing Radiotherapy
by: Ewelina Maślak, et al.
Published: (2022-07-01)

The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients
by: Yat Man Tsang, et al.
Published: (2017-09-01)

Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac
by: A. Mitchell, et al.
Published: (2022-07-01)

Health-related quality of life of metastatic prostate cancer patients treated with prostate Radiotherapy
by: Heba Maged Ayoub, et al.
Published: (2023-10-01)